Product NDC: | 55111-454 |
Proprietary Name: | venlafaxine hydrochloride |
Non Proprietary Name: | venlafaxine hydrochloride |
Active Ingredient(s): | 75 mg/1 & nbsp; venlafaxine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-454 |
Labeler Name: | Dr.Reddy's Laboratories Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078421 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110601 |
Package NDC: | 55111-454-78 |
Package Description: | 10 BLISTER PACK in 1 CARTON (55111-454-78) > 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (55111-454-79) |
NDC Code | 55111-454-78 |
Proprietary Name | venlafaxine hydrochloride |
Package Description | 10 BLISTER PACK in 1 CARTON (55111-454-78) > 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (55111-454-79) |
Product NDC | 55111-454 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | venlafaxine hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110601 |
Marketing Category Name | ANDA |
Labeler Name | Dr.Reddy's Laboratories Ltd. |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |